Jiangsu Zilong Pharmaceutical

Jiangsu Zilong Pharmaceutical, part of Yangtze River Pharmaceutical Group, is an active manufacturer of approved pharmaceuticals, including commercial supply of (S)-ornidazole disodium phosphate for bacterial infections (targeting DNA), with EU EMA and FDA quality compliance. The company's Changzhou site is certified for robust pilot-to-commercial scale manufacturing and supports solid dosage forms, small-volume injections, lyophilized powders, and gel patches. It mainly focuses on contract manufacturing for marketing authorization holders in China and globally, emphasizing both small molecule and biologics manufacturing.[1][3][5]